Selux Diagnostics

Selux Diagnostics is developing technology for next generation phenotyping (NGP). NGP refers to technologies that can rapidly and accurately diagnose and prescribe patients with personalized antibiotic therapies to treat diseases such as infectious diseases. By acting faster with better-informed decisions, more lives can be saved and hospital length stays can be reduced. Selux is using their platform to deliver personalized therapy results for all patients within a day of hospital entry, speeding the targeted treatment by an average of two days. In this manner Selux is advancing their antibiotic susceptibility testing to reduce the incidence of antimicrobial resistance and preserve the power of antibiotics for future generations.

Jobs: